Literature DB >> 23271290

Effect of epigenetic modification of maspin on extravillous trophoblastic function.

Xinwei Shi1, Yuanyuan Wu1, Haiyi Liu1, Xun Gong1, Hui Du1, Yuqi Li1, Jun Zhao1, Ping Chen1, Guiju Tang1, Fuyuan Qiao2.   

Abstract

This study investigated the effect of epigenetic modification of maspin on extravillous trophoblastic function. The mRNA expression of maspin in placentae from normotensive and preeclamptic pregnant women was detected by RT-PCR. TEV-1 cells, a human first-trimester extravillous trophoblast cell line, were cultured and treated with CoCl(2) (300 μmol/L) to induce chemical hypoxia and with 5-aza (500 nmol/L) to induce demethylation. The mRNA expression of maspin in TEV-1 cells subjected to different treatments was determined by RT-PCR, and the proliferative and migratory abilities of TEV-1 cells were assessed by cell counting kit-8 (CCK-8) and Transwell assays. Our results showed that the maspin mRNA expression level in placentae from preeclamptic women was much higher than that from normotensive women. CoCl(2) or 5-aza could up-regulate the mRNA expression of maspin and significantly suppress the proliferation and migration of TEV-1 cells. It was concluded that the epigenetic modification in promoter region of maspin contributes to incomplete trophoblast invasion, which offers a novel approach for predicting and treating placental dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271290     DOI: 10.1007/s11596-012-1051-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  30 in total

1.  Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling.

Authors:  Norihiro Sato; Noriyoshi Fukushima; Hiroyuki Matsubayashi; Michael Goggins
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

2.  5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.

Authors:  R J Wozniak; W T Klimecki; S S Lau; Y Feinstein; B W Futscher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

3.  Expression of maspin in gestational trophoblastic disease.

Authors:  H W Raymond Li; See Wai Leung; Annie N Y Cheung; May M Y Yu; Loucia K Y Chan; Yick Fu Wong
Journal:  Gynecol Oncol       Date:  2005-11-04       Impact factor: 5.482

4.  Epigenetic regulation of maspin expression in human ovarian carcinoma cells.

Authors:  Stephen L Rose; Matthew P Fitzgerald; Natalie O White; Michael J Hitchler; Bernard W Futscher; Koen De Geest; Frederick E Domann
Journal:  Gynecol Oncol       Date:  2006-02-07       Impact factor: 5.482

5.  The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development.

Authors:  A Dokras; L M G Gardner; D A Kirschmann; E A Seftor; M J C Hendrix
Journal:  Placenta       Date:  2002-04       Impact factor: 3.481

6.  The paradoxical expression of maspin in ovarian carcinoma.

Authors:  Anil K Sood; Mavis S Fletcher; Lynn M Gruman; Jeremy E Coffin; Sarvenaz Jabbari; Zhila Khalkhali-Ellis; Nancy Arbour; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

7.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

8.  Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.

Authors:  Kei Wada; Chihaya Maesawa; Toshihide Akasaka; Tomoyuki Masuda
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

9.  Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.

Authors:  Yanyuan Wu; Monica Alvarez; Dennis J Slamon; Phillip Koeffler; Jaydutt V Vadgama
Journal:  BMC Cancer       Date:  2010-02-04       Impact factor: 4.430

10.  Focus on molecules: maspin.

Authors:  Malathi Narayan; Sally Twining
Journal:  Exp Eye Res       Date:  2009-07-15       Impact factor: 3.467

View more
  5 in total

1.  Assessment of the number and function of macrophages in the placenta of gestational diabetes mellitus patients.

Authors:  Jun Yu; Yong Zhou; Juan Gui; Ai-Zhen Li; Xiao-Ling Su; Ling Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

2.  Promoter Hypomethylation of Maspin Inhibits Migration and Invasion of Extravillous Trophoblast Cells during Placentation.

Authors:  Xinwei Shi; Hao Liu; Jing Cao; Qing Liu; Guiju Tang; Wanlu Liu; Haiyi Liu; Dongrui Deng; Fuyuan Qiao; Yuanyuan Wu
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

3.  Placental pseudo-malignancy from a DNA methylation perspective: unanswered questions and future directions.

Authors:  Boris Novakovic; Richard Saffery
Journal:  Front Genet       Date:  2013-12-10       Impact factor: 4.599

Review 4.  DNA methyltransferases and TETs in the regulation of differentiation and invasiveness of extra-villous trophoblasts.

Authors:  Philip C Logan; Murray D Mitchell; Peter E Lobie
Journal:  Front Genet       Date:  2013-12-04       Impact factor: 4.599

5.  Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia.

Authors:  Ying Zhang; Hao Liu; Xinwei Shi; Fuyuan Qiao; Wanjiang Zeng; Ling Feng; Dongrui Deng; Haiyi Liu; Yuanyuan Wu
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-29       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.